{
    "clinical_study": {
        "@rank": "80777", 
        "arm_group": [
            {
                "arm_group_label": "PEG+E", 
                "arm_group_type": "Active Comparator", 
                "description": "Split dose 4 liter polyethylene glycol with electrolytes"
            }, 
            {
                "arm_group_label": "PEG+Asc", 
                "arm_group_type": "Active Comparator", 
                "description": "Split dose 2 liter polyethylene glycol with ascorbic acid"
            }, 
            {
                "arm_group_label": "P+MC", 
                "arm_group_type": "Active Comparator", 
                "description": "Split dose sodium picosulfate, magnesium oxide, and anhydrous citric acid"
            }, 
            {
                "arm_group_label": "sulfate", 
                "arm_group_type": "Active Comparator", 
                "description": "Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution"
            }
        ], 
        "brief_summary": {
            "textblock": "This will be a 4-way comparison to prospectively evaluate the efficacy and patient\n      tolerability of four commercially available bowel preparations among patients undergoing\n      colonoscopy for screening and surveillance in a single tertiary academic medical center."
        }, 
        "brief_title": "Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Patients Undergoing Screening or Surveillance Colonoscopy", 
        "detailed_description": {
            "textblock": "We will randomize 300 consecutive patients undergoing colonoscopy for screening or\n      surveillance purposes to receive one of four bowel purgatives. These purgatives include\n\n        1. Split dose 4 liter polyethylene glycol with electrolytes (PEG+E): Brand name GoLytely\n\n        2. Split dose 2 liter polyethylene glycol with ascorbic acid (PEG+Asc): Brand name:\n           MoviPrep\n\n        3. Split dose sodium picosulfate, magnesium oxide, and anhydrous citric acid (P+MC): Brand\n           name Prepopik\n\n        4. Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution (sulfate):\n           Brand name Suprep"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age 18 years or greater\n\n          2. Ability to understand and complete questionnaires\n\n          3. Ability to speak and read English\n\n          4. Willingness to participate in study\n\n          5. Colonoscopy is being performed for routine screening (i.e. no prior personal history\n             of polyps or cancer) or surveillance (i.e. follow up for a personal history of\n             polyps) purposes\n\n        Exclusion Criteria:\n\n          1. Previous bowel resection of any kind (small or large bowel)\n\n          2. End stage renal disease (ESRD)\n\n          3. Contraindication to bowel purgative\n\n          4. Necessity for inpatient admission to receive bowel preparation for any reason\n\n          5. Currently taking any narcotic/opiate pain or anticholinergic medication (since these\n             may predispose to higher colon stool burden at baseline)\n\n          6. Currently taking stool softeners (e.g. Miralax, Amitiza, Linzess, lactulose) or\n             stimulant laxatives (e.g. Dulcolax)\n\n          7. Subject did not follow appropriate dosing instructions for bowel purgative\n\n          8. Colonoscopy is being performed to evaluate a clinical symptom such as rectal\n             bleeding, constipation, abdominal pain, or diarrhea\n\n          9. History of colon polyposis syndrome\n\n         10. Personal history of inflammatory bowel disease\n\n         11. History of inadequate colon preparation on any prior colonoscopies\n\n         12. Patient is pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02124447", 
            "org_study_id": "PRO00022505"
        }, 
        "intervention": [
            {
                "arm_group_label": "PEG+E", 
                "description": "Split dose 4 liter polyethylene glycol with electrolytes", 
                "intervention_name": "PEG+E", 
                "intervention_type": "Drug", 
                "other_name": "Golytely"
            }, 
            {
                "arm_group_label": "PEG+Asc", 
                "description": "Split dose 2 liter polyethylene glycol with ascorbic acid", 
                "intervention_name": "PEG+Asc", 
                "intervention_type": "Drug", 
                "other_name": "MoviPrep"
            }, 
            {
                "arm_group_label": "P+MC", 
                "description": "Split dose sodium picosulfate, magnesium oxide, and anhydrous citric acid", 
                "intervention_name": "P+MC", 
                "intervention_type": "Drug", 
                "other_name": "Suprep"
            }, 
            {
                "arm_group_label": "sulfate", 
                "description": "Split dose sodium sulfate, magnesium sulfate, and potassium sulfate solution", 
                "intervention_name": "sulfate", 
                "intervention_type": "Drug", 
                "other_name": "Prepopik"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cathartics", 
                "Laxatives", 
                "Magnesium Sulfate", 
                "Citric Acid"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 24, 2014", 
        "location": {
            "contact": {
                "email": "zsmith@mcw.edu", 
                "last_name": "Zachary Smith, DO", 
                "phone": "414-955-6830"
            }, 
            "facility": {
                "address": {
                    "city": "Milwaukee", 
                    "country": "United States", 
                    "state": "Wisconsin", 
                    "zip": "53226"
                }, 
                "name": "Froedtert Hospital & The Medical College of Wisconsin"
            }, 
            "investigator": [
                {
                    "last_name": "Young S Oh, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Zachary L Smith, DO", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Kia Saeian, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Comparison of Efficacy and Patient Tolerability of Four Commercially Available Bowel Purgatives for Screening and Surveillance Colonoscopy: A Single Tertiary Medical Center Experience.", 
        "overall_contact": {
            "email": "zsmith@mcw.edu", 
            "last_name": "Zachary Smith, DO", 
            "phone": "414-955-6830"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Efficacy of bowel cleansing according to the Boston Bowel Preparation Score (BPPS)", 
            "safety_issue": "No", 
            "time_frame": "Patient outcome will be assessed at the time of the colonoscopy by the performing physician and ducomentation of this outcome will occur within 24 hours of the procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02124447"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical College of Wisconsin", 
            "investigator_full_name": "Young Oh, MD", 
            "investigator_title": "Division of Gastroenterology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Will be assessed using a previously studied satisfaction questionnaire (7 items)", 
            "measure": "Patient tolerability and satisfaction", 
            "safety_issue": "No", 
            "time_frame": "Outcome of satisfaction will be assessed on a single survey that the patient will provide the day of their colonoscopy and will be recorded by study personnel up to 30 days thereafter"
        }, 
        "source": "Medical College of Wisconsin", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical College of Wisconsin", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}